Syngenta will leverage Ginkgo's Ag Biologicals
capabilities to optimize secondary metabolite production for a
pioneering biological solution
BASEL,
Switzerland and BOSTON, July 16,
2024 /PRNewswire/ -- Syngenta Crop Protection, a
leader in agricultural innovation, and Ginkgo Bioworks (NYSE: DNA),
which is building the leading platform for cell programming and
biosecurity, today announced a new collaboration aimed at
accelerating the launch of a new biological solution. The two
companies have previously collaborated on next-generation seed
technology.
Through this new collaboration, Ginkgo plans to develop and
optimize a microbial strain that can meet the productivity targets
of a secondary metabolite from the Syngenta Biologicals pipeline.
This molecule is earmarked by Syngenta as a pioneering biological
solution. Successful cost-effective and large-scale production of
this targeted metabolite would significantly expedite Syngenta's
go-to-market timeline for its latest biological solution.
To achieve this, Ginkgo will use its Ag Biologicals capabilities
to calculate theoretical performance and guide rational strain
engineering strategies to develop a microbial strain that is robust
enough to meet Syngenta's goals. Ginkgo will leverage its
biological knowledge and machine learning capabilities to develop
insights from multiple complex data sources and apply this toward
diagnosing strain performance limitations, as well as biological
feature discovery.
Camilla Corsi, Global Head of
Research at Syngenta Crop Protection: "Biologicals are
increasingly important in addressing the need for efficient and
sustainable agricultural solutions worldwide. At Syngenta, we are
committed to providing farmers with greater complementary product
and technology choices that promote sustainable agricultural
practices. We are excited to work with Ginkgo, and are confident
that their distinctive capabilities will enable us to achieve our
productivity goals for our targeted molecule, expediting our time
to market."
Magalie Guilhabert, Head of Ag Biologicals, Ginkgo
Bioworks: "We are so excited to expand our relationship
with Syngenta. We've built a successful relationship from our work
together on plant traits and now look forward to doing the same
with ag biologicals. Ginkgo is proud to put our excellent assets
and experience against some of our customer's toughest challenges.
We'll work to achieve productivity levels to realize commercial
viability for Syngenta's innovative ag biologicals product
launch."
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell
programming, providing flexible, end-to-end services that solve
challenges for organizations across diverse markets, from food and
agriculture to pharmaceuticals to industrial and specialty
chemicals. Ginkgo Biosecurity is building and deploying the
next-generation infrastructure and technologies that global leaders
need to predict, detect, and respond to a wide variety of
biological threats. For more information,
visit ginkgobioworks.com and ginkgobiosecurity.com, read our
blog, or follow us on social media channels such as X (@Ginkgo and
@Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads
(@GinkgoBioworks), or LinkedIn.
To learn more about Ginkgo's Ag Biologicals capabilities, please
visit
https://www.ginkgobioworks.com/offerings/ag-biologicals-discovery-development/#production-strain-engineering.
GINKGO BIOWORKS INVESTOR
CONTACT:
investors@ginkgobioworks.com
GINKGO BIOWORKS MEDIA
CONTACT:
press@ginkgobioworks.com
About Syngenta
Syngenta Crop Protection is a leader in
agricultural innovation, bringing breakthrough technologies and
solutions that enable farmers to grow productively and sustainably.
We offer a leading portfolio of crop protection solutions for plant
and soil health, as well as digital solutions that transform the
decision-making capabilities of farmers. Our 18,300 employees serve
to advance agriculture in more than 90 countries around the world.
Syngenta Crop Protection is headquartered in Basel, Switzerland, and is part of the
Syngenta Group. Follow us on X (@Syngenta, @SyngentaUS), and on
LinkedIn.
Contact Information
media@syngentagroup.com
Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements
within the meaning of the federal securities laws, including
statements regarding the capabilities and potential success of the
partnership and Ginkgo's cell programming platform. These
forward-looking statements generally are identified by the words
"believe," "can," "project," "potential," "expect," "anticipate,"
"estimate," "intend," "strategy," "future," "opportunity," "plan,"
"may," "should," "will," "would," "will be," "will continue," "will
likely result," and similar expressions. Forward-looking statements
are predictions, projections and other statements about future
events that are based on current expectations and assumptions and,
as a result, are subject to risks and uncertainties. Many factors
could cause actual future events to differ materially from the
forward-looking statements in this press release, including but not
limited to: (i) volatility in the price of Ginkgo's securities due
to a variety of factors, including changes in the competitive and
highly regulated industries in which Ginkgo operates and plans to
operate, variations in performance across competitors, and changes
in laws and regulations affecting Ginkgo's business, (ii) the
ability to implement business plans, forecasts, and other
expectations, and to identify and realize additional business
opportunities, (iii) the risk of downturns in demand for products
using synthetic biology, (iv) the uncertainty regarding the demand
for passive monitoring programs and biosecurity services, (v)
changes to the biosecurity industry, including due to advancements
in technology, emerging competition and evolution in industry
demands, standards and regulations, (vi) the outcome of any pending
or potential legal proceedings against Ginkgo, (vii) our ability to
realize the expected benefits from and the success of our Foundry
platform programs, (viii) our ability to successfully develop
engineered cells, bioprocesses, data packages or other
deliverables, and (ix) the product development or commercialization
success of our customers. The foregoing list of factors is not
exhaustive. You should carefully consider the foregoing factors and
the other risks and uncertainties described in the "Risk Factors"
section of Ginkgo's quarterly report on Form 10-Q filed with the
U.S. Securities and Exchange Commission (the "SEC") on May 9, 2024 and other documents filed by Ginkgo
from time to time with the SEC. These filings identify and address
other important risks and uncertainties that could cause actual
events and results to differ materially from those contained in the
forward-looking statements. Forward-looking statements speak only
as of the date they are made. Readers are cautioned not to put
undue reliance on forward-looking statements, and Ginkgo assumes no
obligation and does not intend to update or revise these
forward-looking statements, whether as a result of new information,
future events, or otherwise. Ginkgo does not give any assurance
that it will achieve its expectations.
Syngenta's Cautionary Statement Regarding Forward-Looking
Statements
This document may contain forward-looking statements, which can
be identified by terminology such as 'expect', 'would', 'will',
'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on
track' and similar expressions. Such statements may be subject to
risks and uncertainties that could cause the actual results to
differ materially from these statements. For Syngenta, such risks
and uncertainties include risks relating to legal proceedings,
regulatory approvals, new product development, increasing
competition, customer credit risk, general economic and market
conditions, compliance and remediation, intellectual property
rights, implementation of organizational changes, impairment of
intangible assets, consumer perceptions of genetically modified
crops and organisms or crop protection chemicals, climatic
variations, fluctuations in exchange rates and/or commodity prices,
single source supply arrangements, political uncertainty, natural
disasters, and breaches of data security or other disruptions of
information technology. Syngenta assumes no obligation to update
forward-looking statements to reflect actual results, changed
assumptions or other factors.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syngenta-collaborates-with-ginkgo-bioworks-to-enable-faster-launch-of-innovative-biologicals-302197368.html
SOURCE Ginkgo Bioworks